Enjoy complimentary customisation on priority with our Enterprise License!
The cryogenic vials market size is estimated to grow by USD 66.16 million at a CAGR of 5.38% between 2022 and 2027. The growth of the market depends on several factors, including the increasing adoption of cryopreservation procedures, the growing use of cryogenic vials in drug research and development, and favorable government support and increase in funding.
To learn more about this report, Request Free Sample PDF
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing adoption of cryopreservation procedures is a key factor driving the global market growth. The cryopreservation procedure uses ultra-low temperatures (<150°C) for preserving biological samples. This procedure is finding extensive adoption in a range of applications, such as the preservation of cells and organs, molecular biology and biochemistry, cryosurgery, food sciences, and medical applications, among others. Laboratory clinicians, researchers, and medical practitioners are finding the cryopreservation procedure to be extremely useful in storing samples for a long time and maintaining consistency and reproducibility in these applications.
Substantial demand for artificial insemination has increased cryopreservation practices among IVF centers and fertility clinics. Cryogenic vials are vital for cryopreservation procedures as they are efficient in maintaining optimum storage conditions and the sufficient retrieval of biological materials. Thus, the demand is increasing in tandem with the significant increase in cryopreservation procedures, which, in turn, will drive the growth of the market during the forecast period.
The increasing demand for stem cell cryopreservation is a major market trend. Stem cell-based therapies and treatment options are witnessing increased adoption in pre-clinical and clinical settings. The development of stem cell-based therapies that extensively use hematopoietic stem cells, mesenchymal stem cells, and pluripotent stem cells is gaining traction owing to their increasing use in developing regenerative medicines and personalized treatment options.
The focus on developing methods for cryopreserving induced pluripotent and embryonic stem cells is growing. Advancements in slow cooling protocols and the use of novel storage systems are providing efficient cryopreservation options, which are compliant with GMP requirements, regulations, automation, and scale-up productions. Such advancements are helping in fueling the demand for cryogenic vials, specifically in stem cell-based research applications.
The cross-contamination issues related to poor manufacturing are a major challenge to the market growth. Maintaining the integrity of biomaterials during cryopreservation is of utmost importance and depends on their molecular and macroscopic aspects. The macroscopic aspects involve active sealing capabilities of the manufacturing material of storage systems and their capability to maintain a consistent temperature. However, the shift from glass to plastic cryogenic tubes has brought about significant opportunities for end-users by allowing them to freeze samples with less effort than in conventional vials.
Stringent regulations on the prevention of contamination in preserved samples have compelled end-users to focus largely on factors impacting the control of in-vitro conditions in cryopreservation operations. manufacturing tubes with the efficient selection of materials and their capability of optimum performance in low-temperature conditions are vital requirements, which create a challenging situation for product manufacturers operating in this highly regulated market. Failure to certify the products according to standard requirements adversely impacts Companies' businesses by neutralizing their efforts and resources deployed in product development.
The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates?in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market
Abdos Life Sciences- The company offers cryogenic vials such as Freezing Tubes, Cryo Vial External Thread, and Cryo Coders for External and Internal Threaded Vials.
This market research and growth report covers detailed analyses of the market’s competitive landscape and offers information on 20 market companies, such as
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
Based on type, the market is segmented into internally threaded cryogenic vials and externally threaded cryogenic vials. The market share growth by the segment will be significant during the forecast period. Internally threaded cryogenic vials are the largest segment of the market in 2022 and will continue to be the largest segment during the forecast period. Internally threaded cryogenic vials have screw threads on the inner or concave surface of the vials. Cryogenic vials expand when exposed to extreme temperatures. Though the expansion range in such events is minute, they may expose the biomaterials to the risk of contamination. To overcome such issues, internally threaded segment offer efficient sealing capabilities owing to the equal dimension outside the tube for caps and vials, which expand evenly with a change in temperature. This prevents the risk of contamination and maintains the sterility of biomaterials during extreme conditions.
Request Market Research Report Sample pdf
The choice of cryogenic vials largely depends on the preference of end-users and the manual handling procedures followed during cryopreservation. Internally threaded cryogenic vials provide similar viability and sealing capabilities for biomaterials to externally threaded cryogenic vials. However, end-users find internally threaded cryogenic vials more suitable in terms of their handling during cryopreservation. As a result, the sales of internally threaded cryogenic vials are higher when compared to externally threaded cryogenic vials. Market Companies offer several choices to end-users, ranging from different materials to variations in designs and volume, i.e., ranging from 0.1 ml to 5 ml. Such vials are available with barcodes and easily readable characters to facilitate information storage, tracking, and sharing among end-users. The availability of such internally threaded cryogenic vials with multiple choices and options will fuel the growth of the internally threaded cryogenic vials segment of the global market during the forecast period. Furthermore, our report provides a brief analysis of historical and forecast market share and their segment, along with their reasons for growth from 2017 to 2027.
The growth of this segment is primarily attributed to the increasing adoption of the market by residential consumers, which is driven by changing lifestyles and a growing preference for comfort.
For more insights on the market share of various regions Request Market Research Report Sample pdf
North America is projected to account for 36% of the global market share growth by 2027. Our analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America dominates the market, with the US as the leading market in the region. The increasing need for the cryopreservation of biomaterials such as antibodies; nucleic acids; proteins, cells, and tissue samples in biopharmaceutical research and the growth in cryopreserved sample volumes are boosting the demand in North America. In addition, North America has the presence of a considerable number of prominent Companies in the market offering products with advanced features such as 1-D and 2-D-barcoded cryogenic vials and audit traceability that enable data sharing. The demand for such products is high in North America owing to the increasing adoption of connected IT architecture among biobanks and laboratories.
The Cryogenic Vials Market experiences robust growth, propelled by pharmaceutical enterprises, industrialization, and the expanding geriatric population. Offering various closure types to cater to diverse end users, these vials ensure the cryopreservation of temperature-sensitive samples and viruses with super sealing performance, preventing cross-contamination. Easy sample collection and portability make them indispensable for animal cell culture and health institutes. With the widespread use of liquid nitrogen and advancements in cryopreservation methods, the global cryogenic vials market presents significant revenue opportunities. Governments also play a crucial role in driving market growth by emphasizing the importance of cryopreservation in the research and healthcare sectors.
Our market forecasting report covers revenue growth at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Cryogenic Vials Market Scope |
|
Market Report Coverage |
Details |
Page number |
166 |
Base year |
2022 |
Historical year |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.38% |
Market growth 2023-2027 |
USD 66.16 million |
Market structure |
Fragmented |
YoY growth (%) |
4.83 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 36% |
Key consumer countries |
US, Germany, UK, France, and Japan |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
Abdos Labtech Pvt. Ltd., AHN Biotechnologie GmbH, Avantor Inc., Azer Scientific Inc., Biologix Group Ltd., Brooks Automation Inc., Cole Parmer Instrument Co. LLC, Corning Inc., DWK Life Sciences GmbH, EZ BioResearch LLC, LVL Technologies GmbH & Co. KG, Merck KGaA, Narang Medical Ltd., Pioneer Impex, SARSTEDT AG & Co. KG, Starlab International GMBH, Sumitomo Bakelite Co. Ltd., Thermo Fisher Scientific Inc., Wuxi NEST Biotechnology Co. Ltd., and Ziath Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.